ConductScience.org, home

Paper21773005

Rimonabant: From RIO to Ban.

Sam AH and 2 others. J Obes, 2011. Cited by 185 papers, by iCite.

Cite this record

ConductScience Library. Rimonabant: From RIO to Ban. Papers, record 21773005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21773005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rimonabant: From RIO to Ban.
PubMed
Journal
J Obes
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
185
iCite
Relative citation ratio, by iCite
5.6
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sam AHAmir H
2Salem VVictoria
3Ghatei MAMohammad A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G0701371Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120664173Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.J Clin Invest2010https://conductscience.org/library/papers/20664173PubMed
217098084Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.Lancet2006https://conductscience.org/library/papers/17098084PubMed
37689702Molecular characterization of a peripheral receptor for cannabinoids.Nature1993https://conductscience.org/library/papers/7689702PubMed
415784668A potential decline in life expectancy in the United States in the 21st century.N Engl J Med2005https://conductscience.org/library/papers/15784668PubMed
511298451Leptin-regulated endocannabinoids are involved in maintaining food intake.Nature2001https://conductscience.org/library/papers/11298451PubMed
615836887Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.Lancet2005https://conductscience.org/library/papers/15836887PubMed
712451119Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.J Neurosci2002https://conductscience.org/library/papers/12451119PubMed
818678611
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes.
Diabetes Care2008https://conductscience.org/library/papers/18678611PubMed
99080435Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.Neuroreport1997https://conductscience.org/library/papers/9080435PubMed
1020818901Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.N Engl J Med2010https://conductscience.org/library/papers/20818901PubMed
1112669182Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12669182PubMed
1216140402Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.Behav Brain Res2005https://conductscience.org/library/papers/16140402PubMed
1318022033Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.Lancet2007https://conductscience.org/library/papers/18022033PubMed
1417054276Rimonabant for overweight or obesity.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/17054276PubMed
1516291982Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.N Engl J Med2005https://conductscience.org/library/papers/16291982PubMed
1612897210The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.J Clin Invest2003https://conductscience.org/library/papers/12897210PubMed
1718719634Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic.Obesity (Silver Spring)2008https://conductscience.org/library/papers/18719634PubMed
1816478899Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.JAMA2006https://conductscience.org/library/papers/16478899PubMed

Download CSV of references

Cited by120

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.

PMIDTitleJournalYearIn PapersSource
42965085Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes.ACS Omega2026https://conductscience.org/library/papers/42965085PubMed
42650836Endogenous Lipid Signals in Energy Homeostasis and Fibrosis.Biomolecules2026https://conductscience.org/library/papers/42650836PubMed
42572649Emerging roles of cannabinoid pathways in renal injury and repair.Front Pharmacol2026https://conductscience.org/library/papers/42572649PubMed
42422426Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42422426PubMed
42352627The Neural Network of Orexin-A: Implications in Feeding Regulation and Obesity-Anxiety Comorbidity.Brain Sci2026https://conductscience.org/library/papers/42352627PubMed
42239616An analysis on the role of glucagon-like peptide 1 receptor agonists in cognitive and mental health disorders.Nat Ment Health2025https://conductscience.org/library/papers/42239616PubMed
42004545Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice.Biochem Biophys Rep2026https://conductscience.org/library/papers/42004545PubMed
41965364Not only gut feelings: pancreatic hormone, amylin, controls emotionality and sociability, in a sex divergent manner.Transl Psychiatry2026https://conductscience.org/library/papers/41965364PubMed
41850718Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study.BMJ Open Diabetes Res Care2026https://conductscience.org/library/papers/41850718PubMed
41750191Multiple Roles of Cannabinoids in the Olfactory System.Brain Sci2026https://conductscience.org/library/papers/41750191PubMed
41608471The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease.Front Psychiatry2025https://conductscience.org/library/papers/41608471PubMed
41381865Brain CB2 receptor: a new target in medication development for treating opioid use disorder in rodents.Mol Psychiatry2026https://conductscience.org/library/papers/41381865PubMed
41016636Leptin and G-protein coupled receptor (GPCR) signaling: Therapeutic potential in obesity.J Biol Chem2025https://conductscience.org/library/papers/41016636PubMed
40969876Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40969876PubMed
40822483Barriers to glucagon-like peptide-1 agonists used for obesity management among the general population in Tabuk City, Saudi Arabia, and their relation to smoking cessation and antidepressants.Front Pharmacol2025https://conductscience.org/library/papers/40822483PubMed
40631457Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning.Diabetes Metab J2025https://conductscience.org/library/papers/40631457PubMed
40400441
Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial.
Psychol Med2025https://conductscience.org/library/papers/40400441PubMed
40341983Cannabis, Weight, and Weight-Related Behaviors.Curr Obes Rep2025https://conductscience.org/library/papers/40341983PubMed
40034365A systematic study of molecular targets of cannabidiol in Alzheimer's disease.J Alzheimers Dis Rep2024https://conductscience.org/library/papers/40034365PubMed
39869298Impact of CB1 receptor antagonism on skeletal muscle hypertrophy and metabolic health: a systematic review of preclinical studies.Hormones (Athens)2025https://conductscience.org/library/papers/39869298PubMed

See all 120 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
CNR11268PubTator's text mininghttps://conductscience.org/library/genes/1268NCBI Gene
CNR21269PubTator's text mininghttps://conductscience.org/library/genes/1269NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21773005

GET https://conductscience.org/api/papers/v1/21773005/cited_by?page=2